Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients

Oncotarget

Volumn 7, Issue 21, 2016, Pages 30258-30275

  Gazon, Hélène ^a,b   Belrose, Gildas ^b   Terol, Marie ^a,b   Meniane, Jean Come ^b   Mesnard, Jean Michel ^a   Césaire, Raymond ^b   Peloponese, Jean Marie ^a  

^a University of Montpellier I and II   (France)

^b Centre Hospitalier et Universitaire de Martinique   (Martinique)

Author keywords

AP 1; Dicer; HBZ; JunD; MiRNAs

Indexed keywords

CD4 ANTIGEN; DICER; MICRORNA; PROTEIN C JUN; PROTEIN DICER1; PROTEIN HBZ; TAX PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTINEOPLASTIC AGENT; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; JUND PROTEIN, HUMAN; RIBONUCLEASE III; VALPROIC ACID; VIRAL PROTEIN;

ADULT; ARTICLE; BIOGENESIS; CANCER PATIENT; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; CD4+ T LYMPHOCYTE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HTLV-1 INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; JURKAT CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HEK293 CELLS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MICRORNAS; MIDDLE AGED; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-JUN; RETROVIRIDAE PROTEINS; RIBONUCLEASE III; VALPROIC ACID;

EID: 84969218361     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7162     Document Type: Article

References (51)

1. Duc Dodon M, Mesnard JM and Barbeau B. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ]. Med Sci (Paris). 2010; 26:391-396
2. Matsuoka M and Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2010; 30:1379-1389
3. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, Tamura K, Sano M, Momita S, Yamaguchi K, Kawano F, Hanada S, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007; 25:5458-5464
4. Barbeau B, Peloponese JM and Mesnard JM. Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front Microbiol. 2013; 4:226
5. Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, Kumaran T, Ardeshna KM, Pagliuca A, Taylor GP and Fields PA. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma. J Clin Oncol. 2011; 29:4696-4701
6. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N and Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature. 2004; 432:235-240
7. Winter J, Jung S, Keller S, Gregory RI and Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11:228-234
8. Di Leva G, Garofalo M and Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2013; 9:287-314
9. Lee YS and Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009; 4:199-227
10. Mitamura T, Watari H, Wang L, Kanno H, Hassan MK, Miyazaki M, Katoh Y, Kimura T, Tanino M, Nishihara H, Tanaka S and Sakuragi N. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis. 2013; 2:e40
11. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI and Tan M. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010; 285:21496-21507
12. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L and Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer research. 2010; 70:5184-5193
13. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S and Watanabe T. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012; 21:121-135
14. Boxus M and Willems L. Mechanisms of HTLV-1 persistence and transformation. Br J Cancer. 2009; 101:1497-1501
15. Kuang Y, Cai J, Li D, Han Q, Cao J and Wang Z. Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer. Oncol Lett. 2013; 5:1149-1154
16. Jafarnejad SM, Ardekani GS, Ghaffari M, Martinka M and Li G. Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion. Oncogene. 2013; 32:2131-2139
17. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T and Zamore PD. A cellular function for the RNAinterference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001; 293:834-838
18. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG and Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001; 20:6969-6978
19. Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R, Aragno M and Boccuzzi G. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol. 2006; 191:465-472
20. Sampey GC, Van Duyne R, Currer R, Das R, Narayanan A and Kashanchi F. Complex role of microRNAs in HTLV-1 infections. Front Genet. 2012; 3:295
21. Yamagishi M and Watanabe T. [miRNA in HTLV-1 related disease]. Uirusu. 2012; 62:9-18
22. Allen KE and Weiss GJ. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther. 2010; 9:3126-3136
23. Garofalo M and Croce CM. MicroRNAs as therapeutic targets in chemoresistance. Drug Resist Updat. 2013; 16:47-59
24. Schmitter D, Filkowski J, Sewer A, Pillai RS, Oakeley EJ, Zavolan M, Svoboda P and Filipowicz W. Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res. 2006; 34:4801-4815
25. Clerc I, Polakowski N, Andre-Arpin C, Cook P, Barbeau B, Mesnard JM and Lemasson I. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J Biol Chem. 2008; 283:23903-23913
26. Barbeau B and Mesnard JM. Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs). Viruses. 2011; 3:456-468
27. Levy C, Khaled M, Robinson KC, Veguilla RA, Chen PH, Yokoyama S, Makino E, Lu J, Larue L, Beermann F, Chin L, Bosenberg M, Song JS and Fisher DE. Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell. 2010; 141:994-1005
28. Belrose G, Gross A, Olindo S, Lezin A, Dueymes M, Komla-Soukha I, Smadja D, Tanaka Y, Willems L, Mesnard JM, Peloponese JM, Jr. and Cesaire R. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood. 2011; 118:2483-2491
29. Guo Y, Yan K, Fang J, Qu Q, Zhou M and Chen F. Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma. J Exp Clin Cancer Res. 2013; 32:41
30. Gong Z, Zhang S, Tang K, Li X, Xiang B, Xiang J, Zhou M, Ma J, Zeng Z, Xiong W and Li G. [MicroRNAs and nonresolving inflammation-related cancer]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013; 38:639-644
31. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M and Jeang KT. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer research. 2008; 68:8976-8985
32. Pichler K, Schneider G and Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology. 2008; 5:100
33. Abe M, Suzuki H, Nishitsuji H, Shida H and Takaku H. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing. FEBS Lett. 2010; 584:4313-4318
34. Van Duyne R, Guendel I, Klase Z, Narayanan A, Coley W, Jaworski E, Roman J, Popratiloff A, Mahieux R, Kehn-Hall K and Kashanchi F. Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery. PLoS One. 2012; 7:e40662
35. Vicente C and Cools J. The genomic landscape of adult T cell leukemia/lymphoma. Nature genetics. 2015; 47:1226-1227
36. Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nature genetics. 2015; 47:1304-1315
37. Vernin C, Thenoz M, Pinatel C, Gessain A, Gout O, Delfau-Larue MH, Nazaret N, Legras-Lachuer C, Wattel E and Mortreux F. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer research. 2014; 74:6082-6093
38. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW and Dhir R. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006; 169:1812-1820
39. Faber C, Horst D, Hlubek F and Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer. 2011; 47:1414-1419
40. Yu Z, Wang L, Wang C, Ju X, Wang M, Chen K, Loro E, Li Z, Zhang Y, Wu K, Casimiro MC, Gormley M, Ertel A, Fortina P, Chen Y, Tozeren A, et al. Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer. Nat Commun. 2013; 4:2812
41. Kitagawa N, Ojima H, Shirakihara T, Shimizu H, Kokubu A, Urushidate T, Totoki Y, Kosuge T, Miyagawa S and Shibata T. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci. 2013; 104:543-551
42. Zhao H, Jin X, Su H, Deng X, Fang Y, Shen L and Xie C. Down-regulation of Dicer expression in cervical cancer tissues. Med Oncol. 2014; 31:937
43. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T and Takahashi T. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005; 96:111-115
44. Wu D, Tao J, Xu B, Li P, Lu Q and Zhang W. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. Mol Med Rep. 2012; 5:695-699
45. Kwon SY, Lee JH, Kim B, Park JW, Kwon TK, Kang SH and Kim S. Complexity in Regulation of microRNA Machinery Components in Invasive Breast Carcinoma. Pathol Oncol Res. 2014
46. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW and Dacic S. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer research. 2007; 67:2345-2350
47. Fields PA and Taylor GP. "Antivirals" in the treatment of adult T cell leukaemia-lymphoma (ATLL). Curr Hematol Malig Rep. 2012; 7:267-275
48. Fujii K, Suzuki N, Yamamoto T, Suzuki D and Iwatsuki K. Valproic acid inhibits proliferation of EB virus-infected natural killer cells. Hematology. 2012; 17:163-169
49. Desponts C and Ding S. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells. Methods Mol Biol. 2010; 636:207-218
50. Gazon H, Lemasson I, Polakowski N, Cesaire R, Matsuoka M, Barbeau B, Mesnard JM and Peloponese JM, Jr. Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat. J Virol. 2012; 86:9070-9078
51. Schneider CA, Rasband WS and Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9:671-675